Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Sepracor-Looks very promising -- Ignore unavailable to you. Want to Upgrade?

To: billy d who wrote (1843)	2/25/1999 2:56:00 PM
From: Bob Swift	Respond to of 10280

Billy, I might just add that even if earning is not as high as "hyped", no one will find out until a few years from now. By which time SEPR will be >$500 if not >$1000 a share and most of the millionaires on this board will be in a no loss situation. Who cares what the exact number may be by then. Meanwhile SEPR will continue to go up base on forward projection as the stock market always does. That being said, I think it is more than likely that the earning projection will be far exceeded. In fact,their R&D effort may turn out more and more surprises in the metabolite area. Looks like it may go down a little more today or even tomorrow. How many stock makes you happy when it is either up or down. I am buying a little more at this reasonable <g> price.